Clinical Trial Update: Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravenous iron in patients with severe chronic heart failure and chronic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• Heart Failure

Snippet

Sponsor: Anemia Working Group Romania | Conditions: Chronic Kidney Disease, Chronic Heart Failure | Phase 3 | Status: WITHDRAWN